We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

71 hedge funds and large institutions have $1.47B invested in Roivant Sciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 4

173% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 11

37% more funds holding

Funds holding: 52 → 71 (+19)

0.99% more ownership

Funds ownership: 50.45% → 51.44% (+0.99%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

15% less capital invested

Capital invested by funds: $1.72B → $1.47B (-$258M)

28% less call options, than puts

Call options by funds: $257K | Put options by funds: $355K

Holders
71
Holders Change
+19
Holders Change %
+36.54%
% of All Funds
1.2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
30
Increased
22
Reduced
4
Closed
11
Calls
$257K
Puts
$355K
Net Calls
-$98K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
TSC
Two Seas Capital
New York
+$10.4M
2
BlackRock
BlackRock
New York
+$5.49M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.97M
4
CC
Chicago Capital
Illinois
+$3.72M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.48M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$693K
2
Squarepoint
Squarepoint
New York
-$354K
3
OQS
Occudo Quantitative Strategies
Florida
-$320K
4
Two Sigma Investments
Two Sigma Investments
New York
-$248K
5
Jane Street
Jane Street
New York
-$246K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
51
Rafferty Asset Management
New York
$123K +$120K +30,238 New
SAM
52
Shell Asset Management
Netherlands
$120K +$117K +29,571 New
Squarepoint
53
Squarepoint
New York
$109K -$354K -89,209 -77%
Morgan Stanley
54
Morgan Stanley
New York
$106K +$103K +25,869 +8,265%
TRCT
55
Tower Research Capital (TRC)
New York
$95K +$70.4K +17,737 +308%
Citigroup
56
Citigroup
New York
$85K +$60.3K +15,203 +264%
Bank of America
57
Bank of America
North Carolina
$84K -$239K -60,139 -75%
Barclays
58
Barclays
United Kingdom
$74K +$29.9K +7,535 +71%
PCM
59
Penserra Capital Management
California
$72K +$834 +210 +1%
PAMS
60
Pictet Asset Management (Switzerland)
Switzerland
$65K +$63.9K +16,090 New
EAM
61
Exos Asset Management
New York
$64K – – –
Invesco
62
Invesco
Georgia
$62K +$60.3K +15,189 New
VFA
63
Values First Advisors
Tennessee
$58K +$56.4K +14,200 New
CG
64
Cutler Group
California
$23K – – –
PI
65
PEAK6 Investments
Illinois
$20K +$19.9K +5,001 New
Rockefeller Capital Management
66
Rockefeller Capital Management
New York
$12K +$11.9K +3,000 New
CSS
67
Cubist Systematic Strategies
Connecticut
$4K +$3.96K +998 New
Wells Fargo
68
Wells Fargo
California
$3K +$206 +52 +9%
EBA
69
Eagle Bay Advisors
New York
$2.06K +$2.01K +506 New
FFA
70
Fairfield Financial Advisors
Massachusetts
$2.04K – – –
TSWM
71
Tyler-Stone Wealth Management
Ohio
$1K +$992 +250 New
Millennium Management
72
Millennium Management
New York
– -$693K -140,186 Closed
OQS
73
Occudo Quantitative Strategies
Florida
– -$320K -64,858 Closed
Two Sigma Investments
74
Two Sigma Investments
New York
– -$248K -50,158 Closed
Jane Street
75
Jane Street
New York
– -$246K -49,897 Closed
1 2
3
4

ROIV Hedge Fund Activity: Q2 2022 in Review

71 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2022, worth a combined $1.47B — down 15% from $1.72B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ROIV positions and 11 closed out — a net gain of 19 holders — while 22 added to existing stakes and 4 trimmed.

The largest buyer was Two Seas Capital, adding an estimated $10.4M. The largest seller was Millennium Management, exiting entirely with an estimated $693K sold.

  • 71 institutional investors held Roivant Sciences (ROIV) as of Q2 2022, up from 52 in Q1 2022.
  • Funds reported $1.47B of Roivant Sciences stock for Q2 2022, down 15% quarter-over-quarter.
  • 30 funds opened new Roivant Sciences positions in Q2 2022 and 11 closed out, a net change of +19 holders.
  • The largest Roivant Sciences buyer in Q2 2022 was Two Seas Capital, an estimated $10.4M added.
  • The largest Roivant Sciences seller in Q2 2022 was Millennium Management, an estimated $693K sold.

Based on aggregated 13F filings for Q2 2022.